| Literature DB >> 26907631 |
Ales Janda1, Klaus Schwarz2, Mirjam van der Burg3, Werner Vach4, Hanna Ijspeert3, Myriam Ricarda Lorenz5, Magdeldin Elgizouli6, Kathrin Pieper6, Paul Fisch7, Joachim Hagel6, Raquel Lorenzetti6, Maximilian Seidl8, Joachim Roesler9, Fabian Hauck10, Elisabetta Traggiai11, Carsten Speckmann1, Anne Rensing-Ehl6, Stephan Ehl1, Hermann Eibel6, Marta Rizzi12.
Abstract
Fas is a transmembrane receptor involved in the maintenance of tolerance and immune homeostasis. In murine models, it has been shown to be essential for deletion of autoreactive B cells in the germinal center. The role of Fas in human B-cell selection and in development of autoimmunity in patients carrying FAS mutations is unclear. We analyzed patients with either a somatic FAS mutation or a germline FAS mutation and somatic loss-of-heterozygosity, which allows comparing the fate of B cells with impaired vs normal Fas signaling within the same individual. Class-switched memory B cells showed: accumulation of FAS-mutated B cells; failure to enrich single V, D, J genes and single V-D, D-J gene combinations of the B-cell receptor variable region; increased frequency of variable regions with higher content of positively charged amino acids; and longer CDR3 and maintenance of polyreactive specificities. Importantly, Fas-deficient switched memory B cells showed increased rates of somatic hypermutation. Our data uncover a defect in B-cell selection in patients with FAS mutations, which has implications for the understanding of the pathogenesis of autoimmunity and lymphomagenesis of autoimmune lymphoproliferative syndrome.Entities:
Keywords: ALPS and B cells; ALPS and B-lymphocytes; ALPS and Rizzi; autoimmune lymphoproliferative syndrome and B cells
Mesh:
Substances:
Year: 2016 PMID: 26907631 DOI: 10.1182/blood-2015-04-642488
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113